Background. Although complicated skin and soft-tissue infections (SSTIs) are among the most common infections requiring hospitalization, their clinical spectrum, management, and outcomes have not been well described.
pitalizations for SSTI are now more common than for community-acquired pneumonia, with between 300 and 400 admissions annually.
There is a large body of literature describing the epidemiology, management, and outcomes of inpatient community-acquired pneumonia. In contrast, despite a similar large burden on the health care system, relatively little has been described regarding SSTI in the hospital setting aside from clinical trials of new therapeutic agents. There are likely important opportunities to improve antimicrobial prescribing and use of health care resources for these infections, as has been shown with inpatient community-acquired pneumonia [3] [4] [5] [6] [7] . In addition, there may be added incentive for hospitals to address infection-related care issues, given the increasing focus on infections as markers for quality of care [8] . The purpose of this study was to highlight opportunities for antimicrobial and health care resource stewardship through a detailed description of the clinical spectrum, evaluation, treatment, and outcomes among a cohort of consecutive patients hospitalized for SSTI at a large teaching hospital.
METHODS
Study setting and population. Denver Health is a comprehensive urban health care system. Patients can access care at multiple sites, including a 477-bed hospital, emergency department, urgent care center, community health centers, subspecialty clinics, and the public health department [9] . These sites are linked by a computerized health information system. Study design. We identified patients discharged from the hospital with a principal diagnosis of SSTI from 1 January through 31 December 2007 using International Classification of Diseases, 9th Revision (ICD-9), coding data. The search codes included cellulitis and cutaneous abscess of finger and toe (681.*), other cellulitis and abscess (682.*), erysipelas (035), acute lymphadenitis (683), other infections of skin and subcutaneous tissue (686.*), and necrotizing fasciitis (728.86). For patients with multiple hospitalizations at Denver Health for SSTI during the study period, only the initial episode was reviewed. Demographic information, selected comorbid conditions, and inpatient antibiotic administration were extracted electronically via our health care data warehouse. We verified the discharge diagnosis and obtained information regarding additional comorbidities, microbiological and radiographic studies, drainage procedures, discharge antibiotic therapy, and clinical encounters during the 30 days after hospital discharge via medical record review, using a standardized data collection instrument (T.C.J. and E.E.S.). Patients were excluded for age !18 years, transfer from an outside hospital, refusal of medical care, odontogenic infections or other infections not including the skin, or an alternative diagnosis accounting for the clinical syndrome. Postoperative infections were not included in the ICD-9 case-finding codes, because community-associated infections were the primary focus of this study. The study was approved by the Colorado Multiple Institutional Review Board.
Study definitions. Complicated SSTIs include a spectrum of illnesses ranging from otherwise-uncomplicated cellulitis or abscess requiring hospitalization to diabetic foot infections with osteomyelitis and to necrotizing fasciitis, among others. Therefore, clinical trials of antimicrobial agents for complicated SSTI and other studies of SSTI have involved heterogenous populations [10] [11] [12] [13] [14] [15] [16] [17] [18] . We reviewed these studies and subclassified cases of complicated SSTI into 3 mutually exclusive groups relevant to the treating clinician: (1) cellulitis, (2) cutaneous abscess, or (3) SSTI with additional complicating factors, including deep tissue infection (at or below the deep fascia), bacteremia, intensive care unit admission, diabetic ulcer or other chronic ulcer, peripheral arterial disease, recurrent cellulitis (within 90 days), human or animal bite, severe cellulitis necessitating surgical debridement or fascial biopsy, necrotizing fasciitis, periorbital or perirectal involvement, and hospitalization, surgery, or long-term care facility residence within 90 days. A diagnosis of cellulitis or abscess was based on provider documentation in the medical record. Cutaneous abscess with surrounding erythema or cellulitis was classified as abscess.
Microorganisms (excluding coagulase-negative staphylococci and diphtheroids) were considered to be the etiology of cutaneous abscess or SSTI with additional complicating factors when cultured from an abscess cavity, deep tissue specimen, or blood. Organisms cultured from surface wound swabs were excluded because of uncertain correlation with true pathogens. Needle aspirates or punch biopsies are not routinely performed at our institution. Therefore, cases of cellulitis were not included for evaluation of microbiological etiology.
The primary outcome of interest was clinical failure, a composite end point of treatment failure, recurrence, or rehospitalization due to SSTI within 30 days of hospital discharge. Treatment failure was defined as a change in antimicrobial therapy or the need for additional drainage or debridement 17 days after the initiation of therapy due to inadequate clinical response. Recurrence was defined as evidence of worsening SSTI requiring reinitiation of antibiotic therapy after completion of the initial treatment course.
Data analysis. Differences between the 3 case categorizations in demographics or comorbid conditions, diagnostic testing, microbiological etiology of infection, antimicrobial therapy, and clinical outcomes were assessed using the Pearson x 2 test, the Fisher exact test, or the Wilcoxon rank-sum test, as appropriate. Descriptive statistics were used to summarize the clinical spectrum of SSTIs with additional complicating factors. Differences with were considered significant. We used P ! .05 SAS software, version 9.1 (SAS Institute), for data analysis.
RESULTS
In total, 404 patients with a principal discharge diagnosis of SSTI were identified by ICD-9 coding. More than 90% of the cases captured were coded as other cellulitis and abscess (682.*). Eighty-two patients were excluded for the following reasons: age !18 Diabetes mellitus 12 (18) 14 (14) 47 (31) .004 HIV infection 2 (3) 7 (7) 8 (5) 1.2
Alcohol abuse 12 (18) 15 (15) 22 (14) 1. Prior MRSA infection or colonization 3 (5) 8 (8) 11 (7) 1.2
Prior SSTI 8 (12) 15 (15) 34 (22) .12
Primary location
Lower extremity 50 (76) 25 (24) 79 (52) Upper extremity 12 (18) 42 (41) 46 (30) Groin or buttock 1 (2) 17 (17) 5 (3) Trunk 2 (3) 6 (6) 4 (3) Face, head, or neck 1 (2) 7 (7) 14 (9) Multiple locations 0 6 (6) 5 (3) Duration of symptoms, median days (IQR)
.006 Fever at presentation (temperature, у38.0؇C)
8 (12) 10 (10) 24 (16) 1.2
Failed outpatient therapy 14 (21) 29 (28) 30 (20) Long-term care facility residence 3 (1) cutaneous abscess ( ), whereas diabetes mellitus ( P ! .001 P p ) and cirrhosis ( ) were significantly associated with .004 P p .02 SSTI with additional complicating factors. The lower or upper extremities were the predominant sites of infection for each classification, and the groin and buttock were also frequent sites of cutaneous abscess.
Classification of SSTI with additional complicating factors included a wide spectrum of infections, as shown in Table 2 . Health care-associated infection (hospitalization or surgery within 90 days) was present in 43 (13%) of the 322 patients, and involvement of deep tissues was also common (41 [13%]). Markers of severe infection, including intensive care unit admission, bacteremia, and necrotizing fasciitis, were less common, occurring in 13 (4%), 13 (4%), and 9 (3%) patients, respectively.
The use of diagnostic studies, including laboratory, microbiological, and imaging studies, is summarized in Table 3 . A serum erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) level was determined in nearly 70% of all patients. Blood cultures were frequently ordered among all classifications (47%-58%). Imaging studies were widely used, particularly for cellulitis (94%) and SSTI with additional complicating factors (86%). There was a significant association between cellulitis and the use of plain film radiographs ( ) and ultrasound P ! .004 ( ). Advanced imaging studies, including computed to-P ! .001 mography (CT) or magnetic resonance (MR) imaging, were performed for 20% of all cases. The yield of imaging studies for the identification of deep tissue infection included the following: all imaging studies, 14 (4%) of 322 cases; plain film, 4 (1%); ultrasound, 1 (0.3%); CT image, 7 (2%); and MR image, 3 (1%).
Microbiological data from cases of cutaneous abscess and SSTI with additional complicating factors are presented in Table  4 . Of the 103 cases of cutaneous abscess, incision and drainage was performed in 101 (98%) during the hospitalization or before admission. Of these, 76 (75%) were performed at the bedside. Two facial abscesses were not drained. S. aureus, particularly MRSA, and streptococci were the most prevalent or- ganisms in both groups, isolated from 195% of patients with a positive culture result. Aerobic gram-negative and anaerobic organisms, when identified, were nearly always found in the presence of S. aureus or streptococci and were rarely the sole microorganism identified (4 cases). Isolates from the 13 patients with cases involving bacteremia included MRSA (6), methicillin-susceptible S. aureus (2), b-hemolytic streptococci (2), ahemolytic streptococcus (1), peptostreptococcus (1), and Candida lusitaniae (1) . Ten cases of bacteremia were related to cutaneous abscess, whereas 3 were related to cellulitis without abscess. Clinical data on patients with bacteremia are provided in Table 5 . All patients initially received parenteral antimicrobial therapy during hospitalization. Vancomycin was the most widely used agent, administered to 73%-79% of patients among the 3 classifications for a median of 3 days in each group (Table 6 ). In contrast, the use of gram-positive agents without MRSA activity, including cefazolin and nafcillin, was substantially less common (17%-20% and 4%-8%, respectively). Antimicrobials with a broad spectrum of activity against aerobic gram-negative organisms and anaerobic organisms were administered to 61%-80% of patients (median, 3 days of therapy) and 73%-83% (median, 3-4 days of therapy), respectively. Parenteral b-lactam/ b-lactamase inhibitor combinations comprised the majority of broad-spectrum gram-negative and anaerobic therapy. The median total duration of antimicrobial therapy was 13 days for cellulitis (interquartile range [IQR], 10-14 days) and cutaneous abscess (IQR, 10-16 days) and was 14 days (IQR, 11-17 days) for SSTI with additional complicating factors ( ). P p .003 The primary end point of clinical failure occurred in 12.1%, 4.9%, and 9.2% of patients with cellulitis, cutaneous abscess, and SSTI with additional complicating factors, respectively (Table 7). Although clinical failure was somewhat more common with cellulitis, this difference was not statistically significant. No patients died during hospitalization. SSTI with additional complicating factors resulted in increased hospital charges, compared with cellulitis and cutaneous abscess ( ). P ! .001
DISCUSSION
Cellulitis, cutaneous abscess, and SSTI with additional complicating factors were common causes of hospitalization at our institution. Although there were a wide range of clinical manifestations, more than half involved cellulitis or cutaneous abscess in the absence of other complicating factors. Serum inflammatory markers, blood cultures, and imaging studies were routinely used. Nearly all cases for which an organism was identified involved S. aureus and/or streptococci. For all 3 case classifications, antimicrobial therapy with a broad spectrum of aerobic gram-negative and anaerobic activity was typical. In addition, antimicrobial therapy was generally prolonged with a median duration of nearly 2 weeks, even for cases of cellulitis and cutaneous abscess. Although no deaths occurred, clinical failure occurred in up to 12% of patients.
The umbrella term complicated SSTI encompasses a wide spectrum of clinical disease. Although all cases in our study met the US Food and Drug Administration definition of complicated SSTI, it is important to note that more than half involved cellulitis or cutaneous abscess without other complicating factors. Even though these cases warranted hospitalization, they lacked clinical features of particularly severe illness (eg, need for intensive care, bacteremia, cellulitis requiring surgical debridement or fascial biopsy, and necrotizing fasciitis), clinical features that might raise suspicion for microorganisms beyond typical gram-positive pathogens (eg, health care-associated infections, diabetic foot infections, periorbital cellulitis, and human or animal bites), and clinical features that may be associated with poorly responsive disease or the need for parenteral or prolonged antimicrobial therapy (eg, peripheral arterial disease, deep tissue infection, and bacteremia). Therefore, cellulitis and cutaneous abscess, as defined in our study, are 2 important subsets of complicated SSTIs that may be appropriately grouped in studies of SSTIs. However, further work is needed to better define and group other subsets of complicated SSTIs with therapeutic relevance. The development of more specific and standardized definitions will be critical to this process.
We found that a substantial amount of health care resources were allocated to diagnostic testing, some of which may have been avoidable. In contrast to CRP [19] , there is no defined role for ESR in the evaluation of SSTIs. Despite this, an ESR was measured in more than half of all patients, most often in addition to a CRP level. Although assaying serum inflammatory markers is not expensive, our findings reflect a larger problem of the use of diagnostic studies without clear indications. Likewise, we observed an impressive use of imaging studies among all case classifications despite a poorly defined role for their use [20] [21] [22] . Use of plain film radiographs was particularly common but very low yield, whereas CT or MR imaging was performed in 20% of all cases. Unnecessary use of imaging studies may have an important financial effect for patients and hospitals; therefore, rigorous evaluation of the role of these studies is needed.
Previous studies have shown that cellulitis is caused primarily by b-hemolytic streptococci and less commonly by S. aureus [12, 23, 24] . Whether MRSA has become a more common pathogen in the last decade remains unclear. Recent studies of cellulitis in the outpatient setting have shown that antimicrobial therapy with MRSA activity does not improve outcomes, compared with b-lactams [25, 26] . In our study, 85% of patients with cellulitis received anti-MRSA therapy while hospitalized, whereas only a minority were treated with cefazolin or nafcillin. Moreover, nearly half were discharged to complete a course of trimethoprim-sulfamethoxazole, an agent with reliable activity against MRSA but unclear efficacy against group A streptococci [27] . The high rate of clinical failure we observed for cellulitis (12.1%) is therefore notable, especially given that this is somewhat higher than the failure rates observed in studies of cellulitis/erysipelas treated with penicillin [12] . In fact, 5 (63%) of 8 cases of cellulitis involving clinical failure were discharged with trimethoprim-sulfamethoxazole. One must wonder whether this is a reflection of inadequate therapy against group A streptococci, an inherent risk of recurrent cellulitis even when treated appropriately, or the difficulty in distinguishing cellulitis from other conditions that mimic the erythema, warmth, and swelling typical of cellulitis. Our results highlight the ongoing uncertainties regarding the microbiology of cellulitis in the era of community-associated MRSA and the optimal agent for this condition. Randomized trials are under way that will help elucidate whether MRSA plays a significant role in cases of outpatient cellulitis [28, 29] ; however, it is important to recognize that these results may not be generalizable to more severe cases requiring hospitalization.
We demonstrated that cutaneous abscesses were primarily caused by S. aureus and, less commonly, streptococcal species, a finding consistent with national data [30] . These gram-positive pathogens were isolated in nearly all cases. It is noteworthy that abscesses led to 5 cases of S. aureus bacteremia. Various gram-negative and anaerobic organisms, typically commensals found in the oral cavity, were identified in a subset of cases; however, this is of uncertain clinical relevance. Anaerobic organisms are unlikely to survive in the high oxygen tension associated with abscess drainage. In addition, several studies have suggested that antimicrobial therapy may not be necessary when adequate drainage is achieved [30] [31] [32] [33] . It therefore stands to reason that gram-positive therapy alone would provide sufficient coverage in the vast majority of cutaneous abscesses.
We were surprised to find that despite the gram-positive etiology of most cases of cellulitis and cutaneous abscess, nearly two-thirds of these cases were treated with broad-spectrum gram-negative antimicrobial agents, and even more received broad anaerobic therapy. This is similar to a finding in a previously reported cohort of patients hospitalized with cellulitis [18] . In contrast, only about one-third of patients received therapy targeted only to gram-positive organisms. The median duration of 3 days of gram-negative therapy and 3 days of anaerobic therapy during hospitalization revealed that this was not a trivial amount of unnecessary antibiotic use.
We were also surprised to find the median duration of antimicrobial therapy for cellulitis and cutaneous abscess was nearly 2 weeks, a finding similar to that of a previous study of inpatient cellulitis [18] . This is remarkable in that the limited available evidence suggests that patients hospitalized with cellulitis or cutaneous abscess can be safely treated with courses substantially shorter than 14 days. First, in a randomized trial of the treatment of cellulitis, 5 days of therapy was as effective as 10 days, although only a minority of patients required hospitalization [10] . As discussed previously, the addition of antibiotic therapy may not lead to improved outcomes, compared with abscess drainage alone [30] [31] [32] [33] . However, these studies may not be generalizable to the hospital setting. If antibiotics indeed provide incremental benefit over drainage alone for hospitalized patients, it is likely that a short course of therapy is sufficient. Last, Ruhe et al [11] showed that at least 25% of patients hospitalized with SSTI who had a successful outcome received 7 or fewer days of therapy. Studies of hospitalized patients with cellulitis and cutaneous abscess are needed to determine the optimal choice of antibiotic and duration of therapy in this clinical setting; however, our data suggest that interventions to promote shorter durations of therapy targeted to gram-positive pathogens would substantially decrease unnecessary antibiotic exposure.
This study has several important limitations. First, it was a retrospective cohort study where case finding was dependent on ICD-9 coding from hospital discharge data. This may have led to an underestimation of the true number of hospitalizations for SSTI. In addition, postdischarge visits to other institutions may have been missed, potentially leading to an underestimation of the rate of clinical failure. Second, the study was performed at a single institution, which limits its generalizability. It is likely that the findings regarding utilization of health care resources and antimicrobial therapy are not unique to our institution. Third, we did not assess the appropriateness of laboratory, microbiological, or imaging studies or antimicrobial therapy for individual cases. Therefore, we cannot conclude with certainty that the use of any of these was unnecessary.
In summary, hospitalizations for cellulitis, cutaneous abscess, and SSTI with additional complicating factors inflict a large burden on the health care system. Prevention of unnecessary diagnostic studies and the use of broad-spectrum and prolonged antimicrobial therapy could lead to substantial reductions in health care costs and antibiotic use, providing important targets for antimicrobial stewardship programs.
